Open Peptide Calculatoropen formulas · no sellers

safety · fda · research use only

Are peptides safe? What the FDA says

Are peptides safe? It depends on the product. FDA-approved peptide drugs such as Egrifta and Vyleesi were tested for a specific use; peptides sold as "research use only" were not, and the FDA treats them as unapproved drugs. In August 2026 it cited sellers' "peptide calculator" and bacteriostatic water as evidence.

Open Peptide Calculator editorial teamUpdated 17 sources

Not a loopholeThe FDA's position, repeated in letter after letter, is that a "research use only" label does not decide what a product is. If the evidence shows it is meant for people, it is treated as an unapproved drug.[3]

Are peptides safe? Approved vs research-use

Approved peptides come with tested safety data for one use; research-use peptides come with none.

Approved peptide drugs vs "research use only" peptides
FDA-approved peptide drug"Research use only" peptide
ExampleEgrifta SV (tesamorelin), Vyleesi (bremelanotide)[1][2]BPC-157, TB-500, MOTS-c and many others
Tested for safety and effectYes, in controlled trials for a specific useNo; for several, the FDA found no human data at all
Label with dose, warnings, side effectsYesNo
Quality reviewed by the FDAYesNo
FDA positionApproved for its labeled useUnapproved drug when sold for human use[3]

Even approved peptides have side effects: on the Vyleesi label, 40% of users had nausea, for example.[2] "Safe" is never a property of a molecule alone; it depends on the product, the dose and the person. The rest of this page covers the research-use side, where the FDA has been most active.

What the label means, according to the FDA

A typical 2026 warning letter reads: "Despite statements on your product labeling marketing your products for 'Research Use Only,' and 'not intended for human consumption, medical use, or veterinary use,' evidence obtained from your website establishes that your products are intended to be drugs for human use."[3] On its page about unapproved weight-loss drugs, the FDA says products "falsely labeled 'for research purposes' or 'not for human consumption'" have been "sold directly to consumers for human use with dosing instructions."[4]

The letters also point out that injected products "bypass some of the body's key defenses against toxins and microorganisms".[7]

Calculators, guides and bacteriostatic water as evidence

The FDA looks at everything a seller offers alongside the peptide. Several letters name the very tools this site provides, which is why it is built differently.

What FDA warning letters cited as evidence of intended human use
DateSellerWhat the FDA cited
Feb 26, 2025[5]USApeptide.comBacteriostatic water and packs of insulin syringes offered alongside injectable products
Mar 31, 2026[3]Gram PeptidesSelling bacteriostatic water with the peptides made the water itself a drug, intended "to be used in combination for injection"
Mar 31, 2026[6]Mile High CompoundsDosing content in a "peptide cheat sheet"
Aug 24, 2026[7]Royal PeptidesBacteriostatic water alongside a "peptide guide" and "peptide calculator", which "collectively provide the means to prepare an injectable drug for human administration"
Aug 24, 2026[8]NuScience PeptidesBacteriostatic water alongside a "peptide calculator"
Aug 24, 2026[9]Peak Performance Peptides and two othersBacteriostatic water marketed "as a solvent for reconstituting your products"

How this site differs. Open Peptide Calculator sells nothing, links to no seller and suggests no amounts. It publishes its formulas so the arithmetic can be checked, and it reports the regulatory status of each peptide next to the calculator. A calculator is a tool; the FDA's concern in these letters was sellers using one to help customers inject products that were never approved.

Peptides named in FDA actions

FDA warning letters and import alerts have named BPC-157, TB-500, sermorelin, tesamorelin, PT-141 and ipamorelin.

  • BPC-157 and TB-500: injectable and nasal-spray products sold "for research purposes only" (2023).[10]
  • Sermorelin: sold "for research use only" with weight-loss claims (December 2024).[11]
  • Tesamorelin, PT-141 and ipamorelin blends: offered by several research-peptide sellers warned in August 2026.[7][8][9]
  • Ipamorelin and PT-141: entries on Import Alert 66-41, which lets the FDA detain unapproved drugs at the border.[12]

The risks the FDA lists

For each of the peptides it reviewed, the FDA's safety wording returns to the same few problems:[13]

  • Immunogenicity: the body may mount an immune response against the peptide or its impurities.
  • Impurities and characterization: "peptide-related impurities" and difficulty confirming what the active ingredient actually is.
  • Aggregation: peptide molecules clumping together, flagged for TB-500, ipamorelin and injectable GHK-Cu.
  • Missing human data: for several, including TB-500 and MOTS-c, the FDA found no human exposure data at all.

Real reports exist. One FDA adverse event report describes darkening of the skin and gums after a BPC-157 and TB-500 product labeled "research purposes only"; it recurred when the product was used again.[14] The FDA's complaint system also holds reports about blended TB-500 and BPC-157.[15]

Even HHS, when it relaxed enforcement for compounding six peptides in October 2026, said its goal was to "discourage the continued, widespread use of certain research-use-only peptides supplied by foreign manufacturers that pose a safety risk to US patients."[16] The compounding page covers that policy.

What no calculator can check

No calculator can check what is actually in a vial.

The math assumes the label is trueEvery result on this site assumes the vial contains what it says. Nobody verifies that for a "research use only" product. Purity, sterility, the exact molecule and the real amount are all outside what arithmetic can know.

Reporting a problem

Adverse reactions and product problems can be reported to the FDA through MedWatch, its safety reporting program.[17] If you think you are having a medical emergency, call your local emergency number.

Frequently asked questions

What are the warning signs of an unsafe peptide product?

Signs the FDA has cited in warning letters include a "research use only" label on a product sold with dosing information, and bacteriostatic water, syringes or a "peptide calculator" sold alongside it.[3][7] Any injectable peptide that is not an FDA-approved product has had no FDA review of its identity, purity or sterility.

Are peptides safe?

FDA-approved peptide drugs have tested safety data for their labeled use, along with known side effects. Peptides sold as "research use only" have no such data and are not reviewed by the FDA, which treats them as unapproved drugs when sold for human use.[3]

Is it legal to sell peptides labeled "research use only"?

The FDA treats such products as unapproved new drugs when the evidence shows they are meant for people, regardless of the label, and has issued many warning letters on that basis.[3][7] This site does not give legal advice.

Why did the FDA mention peptide calculators?

In two August 2026 letters, the FDA said sellers offering bacteriostatic water alongside a "peptide calculator" were providing the means to prepare an injectable drug for people, which showed intended human use.[7][8] The concern was the seller's whole offering, not arithmetic in itself.

Are research-use peptides tested for purity?

Not by any regulator. Approved drugs must meet FDA quality standards; products labeled "research use only" are not reviewed by the FDA for identity, purity or sterility.

Sources

  1. Egrifta SV (tesamorelin) prescribing information · FDA label via openFDA, effective July 29, 2026
  2. Vyleesi (bremelanotide) prescribing information · FDA label via openFDA, effective November 5, 2026
  3. Warning letter: Gram Peptides · U.S. Food and Drug Administration, March 31, 2026
  4. FDA's concerns with unapproved GLP-1 drugs used for weight loss · U.S. Food and Drug Administration, content current October 1, 2026
  5. Warning letter: USApeptide.com · U.S. Food and Drug Administration, February 26, 2025
  6. Warning letter: Mile High Compounds LLC · U.S. Food and Drug Administration, March 31, 2026
  7. Warning letter: Royal Peptides LLC · U.S. Food and Drug Administration, August 24, 2026
  8. Warning letter: NuScience Peptides LLC · U.S. Food and Drug Administration, August 24, 2026
  9. Warning letter: Peak Performance Peptides · U.S. Food and Drug Administration, August 24, 2026
  10. Warning letter: Warrior Labz SARMS · U.S. Food and Drug Administration, June 12, 2023
  11. Warning letter: Xcel Research LLC · U.S. Food and Drug Administration, December 10, 2024
  12. Import Alert 66-41: unapproved new drugs promoted in the U.S. · U.S. Food and Drug Administration, published November 12, 2026
  13. Certain bulk drug substances for use in compounding that may present significant safety risks · U.S. Food and Drug Administration, content current April 22, 2026
  14. FDA briefing document: BPC-157-related bulk drug substances · U.S. Food and Drug Administration, Pharmacy Compounding Advisory Committee, July 23, 2026
  15. FDA briefing document: TB-500-related bulk drug substances · U.S. Food and Drug Administration, Pharmacy Compounding Advisory Committee, July 23, 2026
  16. Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances (91 FR 68526) · U.S. Department of Health and Human Services, Federal Register, October 30, 2026
  17. MedWatch: the FDA safety information and adverse event reporting program · U.S. Food and Drug Administration, content current November 12, 2026